Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ACTH-Secreting Pituitary Adenoma
Human Kallikrein 10 Expression in Surgically Removed Human Pituitary Corticotroph Adenomas: An Immunohistochemical Study.
Adenocarcinoma
Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma.
Adenocarcinoma
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Astrocytoma
Prognostic significance of multiple kallikreins in high-grade astrocytoma.
Barrett Esophagus
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Breast Neoplasms
Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B? receptor in breast cancer cells.
Breast Neoplasms
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Breast Neoplasms
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Breast Neoplasms
Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines.
Breast Neoplasms
Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance.
Breast Neoplasms
Human kallikrein 10 ELISA development and validation in breast cancer sera.
Breast Neoplasms
Human kallikrein 10, a predictive marker for breast cancer.
Breast Neoplasms
Identification of KLK10 as a therapeutic target to reverse trastuzumab resistance in breast cancer.
Breast Neoplasms
Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression.
Breast Neoplasms
Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer.
Breast Neoplasms
NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.
Breast Neoplasms
Smad signaling is required to maintain epigenetic silencing during breast cancer progression.
Breast Neoplasms
Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
Carcinoma
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Carcinoma
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Carcinoma
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Carcinoma
Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.
Carcinoma
Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
Carcinoma
Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
Carcinoma, Endometrioid
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
Carcinoma, Hepatocellular
Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Carcinoma, Non-Small-Cell Lung
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Carcinoma, Ovarian Epithelial
Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
Carcinoma, Ovarian Epithelial
Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
Carcinoma, Ovarian Epithelial
The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer.
Carcinoma, Papillary
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
Carcinoma, Renal Cell
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Carcinoma, Squamous Cell
Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.
Colonic Neoplasms
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer.
Colorectal Neoplasms
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Colorectal Neoplasms
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Colorectal Neoplasms
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Colorectal Neoplasms
Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Colorectal Neoplasms
[Expression and single nucleotide polymorphisms of kallikrein 10 in colorectal cancer]
Cysts
The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer.
Dermatitis, Atopic
Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients.
Esophageal Neoplasms
Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity in vitro.
Fibroadenoma
Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer.
Gastrointestinal Neoplasms
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Infections
Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Laryngeal Neoplasms
Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma.
Lung Neoplasms
Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.
Lung Neoplasms
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Neoplasm Metastasis
Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
Neoplasm Metastasis
Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors.
Neoplasm Metastasis
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Neoplasm Metastasis
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Neoplasm Metastasis
MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.
Neoplasm Metastasis
Transcriptional Suppression of miR-7 by MTA2 Induces Sp1-Mediated KLK10 Expression and Metastasis of Cervical Cancer.
Neoplasms
A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma.
Neoplasms
Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Neoplasms
Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
Neoplasms
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Neoplasms
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Neoplasms
Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors.
Neoplasms
Diagnostic Value of Serum Kallikrein-Related Peptidases 6 and 10 Versus CA125 in Ovarian Cancer.
Neoplasms
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Neoplasms
Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients.
Neoplasms
Epigenetic events of disease progression in head and neck squamous cell carcinoma.
Neoplasms
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Neoplasms
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Neoplasms
Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Neoplasms
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Neoplasms
Gene expression in poorly differentiated papillary thyroid carcinomas.
Neoplasms
Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance.
Neoplasms
Human Kallikrein 10 Expression in Surgically Removed Human Pituitary Corticotroph Adenomas: An Immunohistochemical Study.
Neoplasms
Human kallikrein 10: a novel tumor marker for ovarian carcinoma?
Neoplasms
Human tissue kallikreins and testicular cancer.
Neoplasms
Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma.
Neoplasms
Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
Neoplasms
Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers.
Neoplasms
Kallikrein-related peptidase (KLK10) cessation blunts colorectal cancer cell growth and glucose metabolism by regulating the PI3K/Akt/mTOR pathway.
Neoplasms
Kallikrein-related peptidase 10 expression in salivary gland tissues and tumours.
Neoplasms
Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.
Neoplasms
Kallikreins as Markers of Disseminated Tumour Cells in Ovarian Cancer - A Pilot Study.
Neoplasms
KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study.
Neoplasms
Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells.
Neoplasms
Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.
Neoplasms
MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.
Neoplasms
NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.
Neoplasms
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
Neoplasms
Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
Neoplasms
Polymorphisms in Kallikrein7 and 10 genes and oral cancer risks in Taiwan betel quid chewers and smokers.
Neoplasms
Prognostic significance of human tissue kallikrein-related peptidases 6 and 10 in gastric cancer.
Neoplasms
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Neoplasms
Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
Neoplasms
Structural basis for the Zn 2+ inhibition of the zymogen-like kallikrein-related peptidase 10.
Neoplasms
The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer.
Neoplasms
The human kallikrein 10 promoter contains a functional retinoid response element.
Neoplasms
Tissue kallikreins: new players in normal and abnormal cell growth?
Neoplasms
Transcriptional Suppression of miR-7 by MTA2 Induces Sp1-Mediated KLK10 Expression and Metastasis of Cervical Cancer.
Neoplasms
Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity in vitro.
Neoplasms
Urinary kallikrein 10 predicts the incurability of gastric cancer.
Neoplasms
Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer.
Neoplasms, Germ Cell and Embryonal
Human tissue kallikreins and testicular cancer.
Ovarian Neoplasms
Diagnostic Value of Serum Kallikrein-Related Peptidases 6 and 10 Versus CA125 in Ovarian Cancer.
Ovarian Neoplasms
Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients.
Ovarian Neoplasms
Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid.
Ovarian Neoplasms
icb-1 Gene counteracts growth of ovarian cancer cell lines.
Ovarian Neoplasms
Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers.
Ovarian Neoplasms
Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.
Ovarian Neoplasms
Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.
Ovarian Neoplasms
Kallikreins as Markers of Disseminated Tumour Cells in Ovarian Cancer - A Pilot Study.
Ovarian Neoplasms
Parallel overexpression of seven kallikrein genes in ovarian cancer.
Ovarian Neoplasms
Potential markers that complement expression of CA125 in epithelial ovarian cancer.
Ovarian Neoplasms
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.
Ovarian Neoplasms
Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.
Pancreatic Neoplasms
Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Pancreatic Neoplasms
In-silico analysis of kallikrein gene expression in pancreatic and colon cancers.
Pancreatic Neoplasms
Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma.
Peutz-Jeghers Syndrome
Search for the second Peutz-Jeghers syndrome locus: exclusion of the STK13, PRKCG, KLK10, and PSCD2 genes on chromosome 19 and the STK11IP gene on chromosome 2.
Pituitary Neoplasms
Human kallikrein 10 in surgically removed human pituitary adenomas.
Polycystic Kidney Diseases
Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
Prostatic Neoplasms
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Prostatic Neoplasms
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Prostatic Neoplasms
Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
Prostatic Neoplasms
NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.
Prostatic Neoplasms
The Role of Kallikrein10 (KLK10) Polymorphism in Prostate Cancer Susceptibility.
Psoriasis
Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy.
Stomach Neoplasms
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Stomach Neoplasms
Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
Stomach Neoplasms
NES1/KLK10 promotes trastuzumab resistance via activation of PI3K/AKT signaling pathway in gastric cancer.
Stomach Neoplasms
Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer.
Stomach Neoplasms
Urinary kallikrein 10 predicts the incurability of gastric cancer.
Testicular Neoplasms
Human tissue kallikreins and testicular cancer.
Uterine Cervical Neoplasms
MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.
Uterine Cervical Neoplasms
Transcriptional Suppression of miR-7 by MTA2 Induces Sp1-Mediated KLK10 Expression and Metastasis of Cervical Cancer.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
all K10 present in ovarian cancer ascites fluids are in the uncomplexed, zymogen form and have no detectable enzymatic activity
brenda
KLK10 is not methylated in normal breast tissues and fibroadenomas while it is in 5 of 10 breast tumors and in 1 of 10 matching normal tissues
brenda
lower KLK10 levels in pleomorphic adenoma suggests aberrant expression in a tumour that develops primarily from myoepithelial cells
brenda
gene expression
brenda
significantly upregulated
brenda
immunohistochemic expression analysis, overview
brenda
the enzyme is up-regulated in colorectal cancer
brenda
immunohistochemic expression analysis, overview
brenda
Barrett esophagus with and without dysplasia
brenda
significantly upregulated
brenda
early stage
brenda
barely detectable gene expression
brenda
gene expression
brenda
-
brenda
normal strain 76N and oncogenically transforming strain 76R-30
brenda
kallikreins 10 is abundantly expressed in human oral squamous cell carcinoma and may be implicated in malignant progression
brenda
significantly upregulated
brenda
coexpression of KLK10 and KLK6 plays an unfavourable role in pancreatic ductal adenocarcinoma
brenda
immunohistochemic enzyme expression analysis in various surgically removed corticotroph adenoma subtypes: lowest enzyme expression in the silent corticotroph subtypes 1 and 2, compared with nontumorous human adenohypophysial corticotrophs, high enzyme expression in endocrinologically active subtypes, ACTH-secreting adenomas, corticotroph carcinomas, Crooke cell adenomas, Crooke cell carcinomas
brenda
-
brenda
endocrinologically active adrenocorticotropic hormone (ACTH)-producing pituitary tumors and the silent subtypes are immunopositve for kallikrein 10. Immunoexpression of kallikrein 10 in the ACTH-secreting tumors as well as in the Crooke cell tumors is significantly increased when compared with the nonfunctioning tumors and in the corticotrophs of nontumorous pituitaries
brenda
gene expression
brenda
-
brenda
from malignant tumours, adenoid cystic carcinoma and mucoepidermoid carcinoma
brenda
gene expression
brenda
gene expression
brenda
barely detectable gene expression
brenda
-
brenda
lung adenocarcinoma cell line
brenda
-
no mRNA expression, enzyme barely detectable
brenda
-
-
brenda
-
mRNA expression, enzyme detectable
brenda
-
-
brenda
-
downregulation
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
no mRNA expression, enzyme barely detectable
brenda
-
-
brenda
-
hypermethylated KLK10 is frequent in hepatocellular carcinoma
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
no mRNA expression, enzyme barely detectable
brenda
-
-
brenda
-
brenda
-
-
brenda
-
mRNA expression, enzyme detectable
brenda
-
no mRNA expression, enzyme barely detectable
brenda
-
mRNA expression, enzyme detectable
brenda
KLK10 is significantly downregulated as compared to non-cancer samples. CpG island hypermethylation of KLK10 is detected in 46.2% of non-small cell lung cancer tissues
brenda
-
high expression
brenda
-
downregulation due to hypermethylation of exon 3
brenda
-
mRNA expression, enzyme detectable
brenda
-
decreased expression compared to normal cell
brenda
-
-
brenda
-
downregulation
brenda
-
increased mRNA expression compared to normal cells
brenda
-
mRNA expression, enzyme detectable
brenda
-
increased mRNA expression compared to noncancer cells
brenda
expression in normal cells, but no expression in breast cancer cells
brenda
KLK10 is not methylated in normal breast tissues and fibroadenomas while it is in 5 of 10 breast tumors and in 1 of 10 matching normal tissues
brenda
gene expression
brenda
-
gene expression
brenda
-
brenda
significantly upregulated
brenda
-
-
brenda
-
downregulation due to hypermethylation of exon 3
brenda
-
downregulation
brenda
-
no mRNA expression, enzyme barely detectable
brenda
additional information
gene expression is almost lost in breast cancer cell lines
brenda
additional information
no expression in fibroblasts, peripheral blood leukocytes, brain, placenta, lung, liver, skeletal muscle, and kidney
brenda
additional information
significantly increased enzyme expression in dysplastic lesions compared with metaplasia but not between dysplastic lesions and invasive cancers, immunohistochemic analysis, overview
brenda
additional information
-
significantly increased enzyme expression in dysplastic lesions compared with metaplasia but not between dysplastic lesions and invasive cancers, immunohistochemic analysis, overview
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Boeckmann, B.; Bairoch, A.; Apweiler, R.; Blatter, M.C.; Estreicher, A.; Gasteiger, E.; Martin M.J.; Michoud, K.; O'Donovan, C.; Phan, I.; Pilbout, S.; Schneider, M.
The SWISS-PROT protein knowledgebase and its supplement TrEMBL
Nucleic Acids Res.
31
365-370
2003
Homo sapiens (O43240)
brenda
Liu, X.L.; Wazer, D.E.; Watanabe, K.; Band, V.
Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression
Cancer Res.
56
3371-3379
1996
Homo sapiens (O43240)
brenda
Santin, A.D.; Diamandis, E.P.; Bellone, S.; Marizzoni, M.; Bandiera, E.; Palmieri, M.; Papasakelariou, C.; Katsaros, D.; Burnett, A.; Pecorelli, S.
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas
Am. J. Obstet. Gynecol.
194
1296-1302
2006
Homo sapiens
brenda
Zhang, Y.; Bhat, I.; Zeng, M.; Jayal, G.; Wazer, D.E.; Band, H.; Band, V.
Human kallikrein 10, a predictive marker for breast cancer
Biol. Chem.
387
715-721
2006
Homo sapiens
brenda
Planque, C.; Ainciburu, M.; Heuze-Vourch, N.; Regina, S.; de Monte, M.; Courty, Y.
Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues
Biol. Chem.
387
783-788
2006
Homo sapiens
brenda
Yousef, G.M.; White, N.M.; Michael, I.P.; Cho, J.C.; Robb, J.D.; Kurlender, L.; Khan, S.; Diamandis, E.P.
Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker
Tumour Biol.
26
227-235
2005
Homo sapiens (O43240), Homo sapiens
brenda
Sidiropoulos, M.; Pampalakis, G.; Sotiropoulou, G.; Katsaros, D.; Diamandis, E.P.
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers
Tumour Biol.
26
324-336
2005
Homo sapiens
brenda
Petraki, C.D.; Gregorakis, A.K.; Vaslamatzis, M.M.; Papanastasiou, P.A.; Yousef, G.M.; Levesque, M.A.; Diamandis, E.P.
Prognostic Implications of the Immunohistochemical Expression of Human Kallikreins 5, 6, 10 and 11 in Renal Cell Carcinoma
Tumour Biol.
27
1-7
2006
Homo sapiens
brenda
Zeng, M.; Zhang, Y.; Bhat, I.; Wazer, D.E.; Band, H.; Band, V.
The human kallikrein 10 promoter contains a functional retinoid response element
Biol. Chem.
387
741-747
2006
Homo sapiens
brenda
Kulasingam, V.; Diamandis, E.P.
Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines
Biol. Chem.
388
1113-1119
2007
Homo sapiens
brenda
Ewan King, L.; Li, X.; Cheikh Saad Bouh, K.; Pedneault, M.; Chu, C.W.
Human kallikrein 10 ELISA development and validation in breast cancer sera
Clin. Biochem.
40
1057-1062
2007
Homo sapiens
brenda
Feng, B.; Xu, W.B.; Zheng, M.H.; Ma, J.J.; Cai, Q.; Zhang, Y.; Ji, J.; Lu, A.G.; Qu, Y.; Li, J.W.; Wang, M.L.; Hu, W.G.; Liu, B.Y.; Zhu, Z.G.
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer
J. Gastroenterol. Hepatol.
21
1596-1603
2006
Homo sapiens
brenda
Luo, L.; Soosaipillai, A.; Grass, L.; Diamandis, E.P.
Characterization of human kallikreins 6 and 10 in ascites fluid from ovarian cancer patients
Tumour Biol.
27
227-234
2006
Homo sapiens (O43240)
brenda
Kioulafa, M.; Kaklamanis, L.; Stathopoulos, E.; Mavroudis, D.; Georgoulias, V.; Lianidou, E.S.
Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer
Ann. Oncol.
20
1020-1025
2009
Homo sapiens (O43240), Homo sapiens
brenda
Rueckert, F.; Hennig, M.; Petraki, C.D.; Wehrum, D.; Distler, M.; Denz, A.; Schroeder, M.; Dawelbait, G.; Kalthoff, H.; Saeger, H.D.; Diamandis, E.P.; Pilarsky, C.; Gruetzmann, R.
Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
Br. J. Cancer
99
1484-1492
2008
Homo sapiens (O43240)
brenda
Pettus, J.R.; Johnson, J.J.; Shi, Z.; Davis, J.W.; Koblinski, J.; Ghosh, S.; Liu, Y.; Ravosa, M.J.; Frazier, S.; Stack, M.S.
Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity
Histol. Histopathol.
24
197-207
2009
Homo sapiens (O43240)
brenda
Zhang, Y.; Song, H.; Miao, Y.; Wang, R.; Chen, L.
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer
Cancer Sci.
101
934-940
2010
Homo sapiens (Q6ICR6), Homo sapiens
brenda
Lu, C.Y.; Hsieh, S.Y.; Lu, Y.J.; Wu, C.S.; Chen, L.C.; Lo, S.J.; Wu, C.T.; Chou, M.Y.; Huang, T.H.; Chang, Y.S.
Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma
Genes Chromosomes Cancer
48
1057-1068
2009
Homo sapiens
brenda
Talieri, M.; Alexopoulou, D.K.; Scorilas, A.; Kypraios, D.; Arnogiannaki, N.; Devetzi, M.; Patsavela, M.; Xynopoulos, D.
Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer
Tumour Biol.
32
737-744
2011
Homo sapiens
brenda
Di Meo, A.; Rotondo, F.; Kovacs, K.; Cusimano, M.D.; Syro, L.V.; Di Ieva, A.; Diamandis, E.P.; Yousef, G.M.
Human kallikrein 10 expression in surgically removed human pituitary corticotroph adenomas: an immunohistochemical study
Appl. Immunohistochem. Mol. Morphol.
23
433-437
2014
Homo sapiens (O43240), Homo sapiens
brenda
Grin, A.; Samaan, S.; Tripathi, M.; Rotondo, F.; Kovacs, K.; Bassily, M.N.; Yousef, G.M.
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma
Hum. Pathol.
46
541-548
2015
Homo sapiens (O43240), Homo sapiens
brenda
Darling, M.R.; Hashem, N.N.; Zhang, I.; Mohamed, A.B.; Fung, K.; Kwan, K.; Mara, T.W.; Daley, T.D.; Diamandis, E.P.
Kallikrein-related peptidase 10 expression in salivary gland tissues and tumours
Int. J. Biol. Markers
27
e381-e388
2013
Homo sapiens (O43240)
brenda
Petraki, C.; Youssef, Y.M.; Dubinski, W.; Lichner, Z.; Scorilas, A.; Pasic, M.D.; Komborozos, V.; Khalil, B.; Streutker, C.; Diamandis, E.P.; Yousef, G.M.
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer
Tumour Biol.
33
1209-1214
2012
Homo sapiens (O43240), Homo sapiens
brenda
Geng, X.; Liu, Y.; Dreyer, T.; Bronger, H.; Drecoll, E.; Magdolen, V.; Dorn, J.
Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients
Am. J. Cancer Res.
8
1856-1864
2018
Homo sapiens (O43240), Homo sapiens
brenda
Di Meo, A.; Rotondo, F.; Kovacs, K.; Cusimano, M.; Syro, L.; Di Ieva, A.; Diamandis, E.; Yousef, G.
Human kallikrein 10 expression in surgically removed human pituitary corticotroph adenomas an immunohistochemical study
Appl. Immunohistochem. Mol. Morphol.
23
433-437
2015
Homo sapiens (O43240), Homo sapiens
brenda
Shimura, T.; Ebi, M.; Yamada, T.; Yamada, T.; Katano, T.; Nojiri, Y.; Iwasaki, H.; Nomura, S.; Hayashi, N.; Mori, Y.; Kataoka, H.; Moses, M.A.; Joh, T.
Urinary kallikrein 10 predicts the incurability of gastric cancer
Oncotarget
8
29247-29257
2017
Homo sapiens (O43240), Homo sapiens
brenda